By mechanically penetrating the stratum corneum with microarrays patch, drugs/ingredients are directly delivered to the dermis, enhancing bioavailability by much higher times compared to traditional transdermal patches. Its "self-driven" dissolution characteristic ensures gradient release of the drug in tissue fluid.

Users simply need to apply gentle pressure for 30 seconds to achieve a painless administration, effectively removing the psychological barriers often associated with syringes. The microneedles begin the dissolution process in just 2 minutes, with full drug/ingredient release occurring within 5-15 minutes, providing an onset speed that rivals that of intravenous injections in urgent situations.

The temperature-stable formulation eliminates the need for cold chain transport. The lightweight patch packaging increases shipping capacity by 200%, making it especially suitable for tropical regions. The pre-loaded, ready-to-use design eliminates steps such as cold chain reconstruction and syringe assembly, reducing labor costs.

Using our Know-How technology, the drug molecules are directly embedded in the microneedle matrix, allowing for use without preparing a liquid solution, eliminating the risk of dosage errors due to reconstitution mistakes. The pre-packaged, sterile patches are ready to use upon opening, ensuring dosing accuracy even in non-professional environments, such as home self-treatment.